Disruption of Myc-Max heterodimerization with improved cell- penetrating analogs of the small molecule 10074-G5

40Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

The c-Myc (Myc) oncoprotein is a high-value therapeutic target given that is deregulated in multiple types of cancer. However, potent small molecule inhibitors of Myc have been difficult to identify, particularly those whose mechanism relies on blocking the association between Myc and its obligate heterodimerization partner, Max. We have recently reported a structure-activity relationship study of one such small molecule, 10074-G5, and generated an analog, JY-3-094, with significantly improved ability to prevent or disrupt the association between recombinant Myc and Max proteins. However, JY-3094 penetrates cells poorly. Here, we show that esterification of a critical para-carboxylic acid function of JY-3-094 by various blocking groups significantly improves cellular uptake although it impairs the ability to disrupt Myc-Max association in vitro. These pro-drugs are highly concentrated within cells where JY-3-094 is then generated by the action of esterases. However, the prodrugs are also variably susceptible to extracellular esterases, which can deplete extracellular reservoirs. Furthermore, while JY-3-094 is retained by cells for long periods of time, much of it is compartmentalized within the cytoplasm in a form that appears to be less available to interact with Myc. Our results suggest that persistently high extracellular levels of pro-drug, without excessive susceptibility to extracellular esterases, are critical to establishing and maintaining intracellular levels of JY-3-094 that are sufficient to provide for long-term inhibition of Myc-Max association. Analogs of JY-3-094 appear to represent promising small molecule Myc inhibitors that warrant further optimization.

Cite

CITATION STYLE

APA

Wang, H., Chauhan, J., Hu, A., Pendleton, K., Yap, J. L., Sabato, P. E., … Prochownik, E. V. (2013). Disruption of Myc-Max heterodimerization with improved cell- penetrating analogs of the small molecule 10074-G5. Oncotarget, 4(6), 936–947. https://doi.org/10.18632/oncotarget.1108

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free